Arbidol
Arbidol is a Russian-produced antiviral product brand for the treatment and prevention of influenza and acute respiratory viral infections (ARVI).
Last updated September 15, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Arbidol is an antiviral product brand produced in Russia and presented on its official site as intended for the treatment and prevention of influenza and acute respiratory viral infections (ARVI). The brand's official materials state that it acts directly on viruses by blocking their entry into cells, their multiplication and spread, and describe a mechanism of inhibiting virus attachment to cells (fusion). The official site presents Arbidol in several dosage forms and strengths, including a suspension, tablets and capsules, with age-related dosing information.
Products and positioning
Antiviral product for the treatment and prevention of influenza and ARVI.
Arbidol suspension
Suspension with a dosage of 25 mg (5 ml), indicated from 2 years of age.
Arbidol tablets
Tablets with a dosage of 50 mg, indicated from 3 years of age; supplied as 10 or 20 tablets.
Arbidol capsules
Capsules with a dosage of 100 mg, indicated from 6 years of age; supplied as 10 or 20 capsules.
Arbidol Maximum capsules
Capsules with a dosage of 200 mg, indicated from 12 years of age; supplied as 10 or 20 capsules.
Sources2 sources
Cite this profile: Cite the canonical profile. /brand-wiki/arbidol · Editorial policy · How profiles are compiled